Market Research Logo

Foamix Pharmaceuticals Ltd. - Product Pipeline Review - 2016

Foamix Pharmaceuticals Ltd. - Product Pipeline Review - 2016

Summary

Global Markets Direct’s, ‘Foamix Pharmaceuticals Ltd. - Product Pipeline Review - 2016’, provides an overview of the Foamix Pharmaceuticals Ltd.’s pharmaceutical research and development focus.

The report provides comprehensive information on the therapeutics under development by Foamix Pharmaceuticals Ltd., complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers the descriptive pharmacological action of the therapeutics, its complete research and development history and the dormant and discontinued projects.

Global Markets Direct’s report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. The report is built using data and information sourced from Global Markets Direct’s proprietary databases, company/university websites, clinical trial registries, conferences, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources. Drug profiles featured in the report undergoes periodic review following a stringent set of processes to ensure that all the profiles are updated with the latest set of information. Additionally, various dynamic tracking processes ensure that the most recent developments are captured on a real time basis.

The report helps in identifying and tracking emerging players in the market and their portfolios, enhances decision making capabilities and helps to create effective counter strategies to gain competitive advantage.

Note:*:Certain sections in the report may be removed or altered based on the availability and relevance of data.

Scope

  • The report provides a snapshot of the pipeline therapeutic landscape of Foamix Pharmaceuticals Ltd.
  • The report provides overview of Foamix Pharmaceuticals Ltd. including its business description, key facts, and locations and subsidiaries
  • The report features descriptive drug profiles for the pipeline products which includes, product description, descriptive MoA, R&D brief, licensing and collaboration details & other developmental activities
  • The report covers pipeline products based on various stages of development ranging from pre-registration till discovery and undisclosed stages
  • The report assesses Foamix Pharmaceuticals Ltd.’s pipeline therapeutics based on drug target, mechanism of action (MoA), route of administration (RoA) and molecule type
  • The report features Foamix Pharmaceuticals Ltd.’s out-licensed and partnered product portfolio and summarizes its dormant and discontinued projects
Reasons to buy
  • Evaluate Foamix Pharmaceuticals Ltd.’s strategic position with total access to detailed information on its product pipeline
  • Gain strategically significant competitor information, analysis, and insights to formulate effective R&D strategies
  • Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
  • Identify and understand important and diverse types of therapeutics under development for Foamix Pharmaceuticals Ltd.
  • Identify potential new clients or partners in the target demographic
  • Plan mergers and acquisitions effectively by identifying key players and it’s most promising pipeline therapeutics
  • Devise corrective measures for pipeline projects by understanding Foamix Pharmaceuticals Ltd.’s pipeline depth and focus of pipeline therapeutics
  • Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope


Foamix Pharmaceuticals Ltd. Snapshot
Foamix Pharmaceuticals Ltd. Overview
Key Facts
Foamix Pharmaceuticals Ltd. - Research and Development Overview
Key Therapeutic Areas
Foamix Pharmaceuticals Ltd. - Pipeline Review
Pipeline Products by Stage of Development
Pipeline Products - Monotherapy
Pipeline Products - Combination Treatment Modalities
Pipeline Products - Partnered Products
Partnered Products/Combination Treatment Modalities
Foamix Pharmaceuticals Ltd. - Pipeline Products Glance
Foamix Pharmaceuticals Ltd. - Late Stage Pipeline Products
Phase III Products/Combination Treatment Modalities
Foamix Pharmaceuticals Ltd. - Clinical Stage Pipeline Products
Phase II Products/Combination Treatment Modalities
Phase I Products/Combination Treatment Modalities
Foamix Pharmaceuticals Ltd. - Early Stage Pipeline Products
Preclinical Products/Combination Treatment Modalities
Foamix Pharmaceuticals Ltd. - Drug Profiles
(urea + lactic acid) - Drug Profile
Product Description
Mechanism Of Action
R&D Progress
acyclovir - Drug Profile
Product Description
Mechanism Of Action
R&D Progress
benzoyl peroxide - Drug Profile
Product Description
Mechanism Of Action
R&D Progress
betamethasone valerate - Drug Profile
Product Description
Mechanism Of Action
R&D Progress
ciclopirox olamine - Drug Profile
Product Description
Mechanism Of Action
R&D Progress
doxycycline - Drug Profile
Product Description
Mechanism Of Action
R&D Progress
estradiol hemihydrate - Drug Profile
Product Description
Mechanism Of Action
R&D Progress
FMX-101 - Drug Profile
Product Description
Mechanism Of Action
R&D Progress
FMX-102 - Drug Profile
Product Description
Mechanism Of Action
R&D Progress
FMX-103 - Drug Profile
Product Description
Mechanism Of Action
R&D Progress
imiquimod - Drug Profile
Product Description
Mechanism Of Action
R&D Progress
mometasone furoate - Drug Profile
Product Description
Mechanism Of Action
R&D Progress
urea - Drug Profile
Product Description
Mechanism Of Action
R&D Progress
Foamix Pharmaceuticals Ltd. - Pipeline Analysis
Foamix Pharmaceuticals Ltd. - Pipeline Products by Target
Foamix Pharmaceuticals Ltd. - Pipeline Products by Route of Administration
Foamix Pharmaceuticals Ltd. - Pipeline Products by Molecule Type
Foamix Pharmaceuticals Ltd. - Pipeline Products by Mechanism of Action
Foamix Pharmaceuticals Ltd. - Dormant Projects
Foamix Pharmaceuticals Ltd. - Locations And Subsidiaries
Head Office
Other Locations & Subsidiaries
Appendix
Methodology
Coverage
Secondary Research
Primary Research
Expert Panel Validation
Contact Us
Disclaimer
List of Tables
Foamix Pharmaceuticals Ltd., Key Facts
Foamix Pharmaceuticals Ltd. - Pipeline by Indication, 2016
Foamix Pharmaceuticals Ltd. - Pipeline by Stage of Development, 2016
Foamix Pharmaceuticals Ltd. - Monotherapy Products in Pipeline, 2016
Foamix Pharmaceuticals Ltd. - Combination Treatment Modalities in Pipeline, 2016
Foamix Pharmaceuticals Ltd. - Partnered Products in Pipeline, 2016
Foamix Pharmaceuticals Ltd. - Partnered Products/ Combination Treatment Modalities, 2016
Foamix Pharmaceuticals Ltd. - Phase III, 2016
Foamix Pharmaceuticals Ltd. - Phase II, 2016
Foamix Pharmaceuticals Ltd. - Phase I, 2016
Foamix Pharmaceuticals Ltd. - Preclinical, 2016
Foamix Pharmaceuticals Ltd. - Pipeline by Target, 2016
Foamix Pharmaceuticals Ltd. - Pipeline by Route of Administration, 2016
Foamix Pharmaceuticals Ltd. - Pipeline by Molecule Type, 2016
Foamix Pharmaceuticals Ltd. - Pipeline Products by Mechanism of Action, 2016
Foamix Pharmaceuticals Ltd. - Dormant Developmental Projects,2016
Foamix Pharmaceuticals Ltd., Subsidiaries
List of Figures
Foamix Pharmaceuticals Ltd. - Pipeline by Top 10 Indication, 2016
Foamix Pharmaceuticals Ltd. - Pipeline by Stage of Development, 2016
Foamix Pharmaceuticals Ltd. - Monotherapy Products in Pipeline, 2016
Foamix Pharmaceuticals Ltd. - Pipeline by Target, 2016
Foamix Pharmaceuticals Ltd. - Pipeline by Route of Administration, 2016
Foamix Pharmaceuticals Ltd. - Pipeline by Molecule Type, 2016
Foamix Pharmaceuticals Ltd. - Pipeline Products by Mechanism of Action, 2016

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook

Share this report